Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 572

1.

Dabigatran for the prevention and treatment of thromboembolic disorders.

Enriquez A, Baranchuk A, Redfearn D, Simpson C, Abdollah H, Michael K.

Expert Rev Cardiovasc Ther. 2015 May;13(5):529-40. doi: 10.1586/14779072.2015.1034692. Epub 2015 Apr 5.

PMID:
25843430
2.

Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.

Shields AM, Lip GY.

J Intern Med. 2015 Mar 10. doi: 10.1111/joim.12360. [Epub ahead of print]

PMID:
25758241
3.

The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.

Sengupta N, Feuerstein JD, Patwardhan VR, Tapper EB, Ketwaroo GA, Thaker AM, Leffler DA.

Am J Gastroenterol. 2015 Feb;110(2):328-35. doi: 10.1038/ajg.2014.398. Epub 2014 Dec 16. Erratum in: Am J Gastroenterol. 2015 Mar;110(3):480.

PMID:
25512338
4.

Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation – subanalysis of the J-RHYTHM Registry.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T; J-RHYTHM Registry Investigators.

Circ J. 2015;79(2):325-30. doi: 10.1253/circj.CJ-14-1057. Epub 2014 Dec 10.

5.

Parenteral anticoagulation in ambulatory patients with cancer.

Akl EA, Kahale LA, Ballout RA, Barba M, Yosuico VE, van Doormaal FF, Middeldorp S, Bryant A, Schünemann H.

Cochrane Database Syst Rev. 2014 Dec 10;12:CD006652. doi: 10.1002/14651858.CD006652.pub4. Review.

PMID:
25491949
6.

[Laboratory assessment of haemostatic parameters in patients taking a direct thrombin inhibitor].

Beliavskaia OO, Vavilova TV.

Angiol Sosud Khir. 2014;20(4):37-41. Russian.

PMID:
25490355
7.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
8.

Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).

Ashburner JM, Go AS, Reynolds K, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE.

Am J Cardiol. 2015 Jan 1;115(1):40-6. doi: 10.1016/j.amjcard.2014.10.006. Epub 2014 Oct 12.

PMID:
25456871
9.

Monitoring and reversal strategies for new oral anticoagulants.

Vanden Daelen S, Peetermans M, Vanassche T, Verhamme P, Vandermeulen E.

Expert Rev Cardiovasc Ther. 2015 Jan;13(1):95-103. doi: 10.1586/14779072.2015.987126. Epub 2014 Nov 28.

PMID:
25431993
10.

A case of cerebral venous sinus thrombosis associated with Crohn's disease: dilemma in management.

Kwon Y, Koene RJ, Cho Y.

Gastroenterol Rep (Oxf). 2014 Nov 10. pii: gou079. [Epub ahead of print]

11.
12.

Bridging therapy in antiphospholipid syndrome and antiphospholipid antibodies carriers: case series and review of the literature.

Raso S, Sciascia S, Kuzenko A, Castagno I, Marozio L, Bertero MT.

Autoimmun Rev. 2015 Jan;14(1):36-42. doi: 10.1016/j.autrev.2014.09.002. Epub 2014 Sep 18. Review.

PMID:
25242343
13.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Otten HM, Rutjes AW.

Cochrane Database Syst Rev. 2014 Aug 29;8:CD008500. doi: 10.1002/14651858.CD008500.pub3. Review.

PMID:
25171736
14.

Effect of preinjury warfarin use on outcomes after head trauma in Medicare beneficiaries.

Collins CE, Witkowski ER, Flahive JM, Anderson FA Jr, Santry HP.

Am J Surg. 2014 Oct;208(4):544-549.e1. doi: 10.1016/j.amjsurg.2014.05.019. Epub 2014 Jul 24.

PMID:
25129426
15.

Efficacy and cost-effectiveness of dabigatran etexilate versus warfarin in atrial fibrillation in different age subgroups.

Clemens A, Peng S, Brand S, Brueckmann M, Kansal A, Lim J, Noack H, Sander S, Sorensen S.

Am J Cardiol. 2014 Sep 15;114(6):849-55. doi: 10.1016/j.amjcard.2014.06.015. Epub 2014 Jul 2.

16.

Outcome following intracranial hemorrhage associated with novel oral anticoagulants.

Kasliwal MK, Panos NG, Munoz LF, Moftakhar R, Lopes DK, Byrne RW.

J Clin Neurosci. 2015 Jan;22(1):212-5. doi: 10.1016/j.jocn.2014.04.025. Epub 2014 Jul 25.

PMID:
25065949
17.

Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.

Uhm JS, Won H, Joung B, Nam GB, Choi KJ, Lee MH, Kim YH, Pak HN.

Yonsei Med J. 2014 Sep;55(5):1238-45. doi: 10.3349/ymj.2014.55.5.1238.

18.

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.

Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci PM.

J Thromb Haemost. 2014 Sep;12(9):1480-7. doi: 10.1111/jth.12647. Epub 2014 Jul 24.

PMID:
25040440
19.

Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.

Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Udaltsova N, Fang MC.

Am J Cardiol. 2014 Aug 15;114(4):583-6. doi: 10.1016/j.amjcard.2014.05.037. Epub 2014 Jun 5.

PMID:
25001151
20.

Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.

Chen WC, Chen YH, Hsu PI, Tsay FW, Chan HH, Cheng JS, Lai KH.

Biomed Res Int. 2014;2014:463767. doi: 10.1155/2014/463767. Epub 2014 May 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk